首页> 外文期刊>Experimental and clinical transplantation >Relationship Between Preoperative Diastolic Transpulmonary Gradient With Pulmonary Vascular Resistance and 1-Year and Overall Mortality Rates Among Patients Undergoing Cardiac Transplant
【24h】

Relationship Between Preoperative Diastolic Transpulmonary Gradient With Pulmonary Vascular Resistance and 1-Year and Overall Mortality Rates Among Patients Undergoing Cardiac Transplant

机译:心脏移植患者术前舒张压肺梯度与肺血管阻力和1年死亡率和总死亡率之间的关系

获取原文
           

摘要

Objectives: Cardiac transplant is a life-saving procedure for patients with end-stage heart failure. Preoperative pulmonary vascular resistance is indicative of intrinsic pulmonary vascular disease and correlates with posttransplant survival. However, its measurement is costly and time consuming. Therefore, simpler techniques are required. Diastolic transpulmonary gradient reportedly indicates intrinsic pulmonary vascular disease. Here, we investigated the relationship between preoperative diastolic transpulmonary gradient with preoperative pulmonary vascular resistance and 1-year and overall mortality among cardiac transplant patients. Materials and Methods: Fifty-one patients who underwent cardiac transplant between 2006 and 2017 were included. All patients underwent preoperative right and left heart catheterization and oxygen study. Among these, diastolic transpulmonary gradient, mean transpulmonary gradient, and pulmonary vascular resistance were correlated with one another and 1st-year and overall mortality rates. Patients were grouped according to whether they received diastolic transpulmonary gradient or not, and both groups were compared with respect to 1-year and overall mortality. Binary logistic regression analysis was done to test whether diastolic transpulmonary gradient was a significant predictor of 1-year and overall mortality. Results: Mean patient age was 45.5 ?±9.8 years. The 1-year and overall mortality rates were 21.6% (11/51) and 37.3% (19/51), respectively. Diastolic transpul?-monary gradient was significantly correlated with pulmonary vascular resistance, 1-year mortality, and overall mortality (P .05) and was a significant predictor of 1-year and overall mortality (odds ratio 6.0; 95% confidence interval, 1.4-25.3; P .05 and odds ratio 4.8; 95% CI, 1.4-17.5; P .05, respectively). Patients with a diastolic transpulmonary gradient of ≥ 7 mm Hg had significantly higher 1-year and overall mortality (P .05). Conclusions: Diastolic transpulmonary gradient can be used as a promising easy-to-use parameter of intrinsic pulmonary vascular disease and a predictor of 1-year and overall mortality among patients undergoing cardiac transplant.
机译:目的:心脏移植是终末期心力衰竭患者的一种挽救生命的程序。术前肺血管阻力预示着内在的肺血管疾病,并与移植后的生存相关。然而,其测量是昂贵且费时的。因此,需要更简单的技术。据报道,舒张压跨肺梯度提示内在性肺血管疾病。在这里,我们调查了心脏移植患者术前舒张压跨肺梯度与术前肺血管阻力以及1年和总死亡率之间的关系。材料与方法:纳入2006年至2017年间接受心脏移植的51例患者。所有患者均接受术前右,左心导管检查和氧气检查。其中,舒张压跨肺梯度,平均跨肺梯度和肺血管阻力相互关联,并与第一年和总死亡率相关。根据患者是否接受舒张压经肺梯度进行分组,并比较两组的一年死亡率和总死亡率。进行了二进制逻辑回归分析以检验舒张压跨肺梯度是否是1年死亡率和总死亡率的重要预测指标。结果:平均患者年龄为45.5±±9.8岁。 1年死亡率和总死亡率分别为21.6%(11/51)和37.3%(19/51)。舒张期跨肺单梯度与肺血管阻力,1年死亡率和总死亡率(P <.05)显着相关,并且是1年死亡率和总死亡率的重要预测指标(优势比6.0; 95%置信区间1.4-25.3; P <.05和优势比4.8; 95%CI,1.4-17.5; P <.05)。舒张压跨肺梯度≥7 mm Hg的患者的一年和总体死亡率显着更高(P <.05)。结论:舒张压跨肺梯度可以作为有希望的易于使用的内在性肺血管疾病参数,并可以预测心脏移植患者的1年死亡率和总死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号